<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>14</Volume><Issue>2</Issue><PubDate PubStatus="epublish"><Year>2023</Year><Month>04</Month><Day>03</Day></PubDate></Journal><title locale="en_US">COVID‑19 Vaccination and Usefulness in Prevention of Mortality Among the Elderly: An Analysis</title><FirstPage>2776</FirstPage><LastPage>2776</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Medical Academic Center, Bangkok</affiliation></Author><Author><affiliation locale="en_US">Department of Community Medicine, Dr DY Patil Vidhayapeeth, Pune, India &amp; Adjunct Professor, Department of Biological Science, Joseph Ayobabalola University, Ikeji‑Arakeji, Nigeria</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2023</Year><Month>03</Month><Day>19</Day></PubDate></History><abstract locale="en_US">Dear editor, COVID‑19 is the new vaccine that becomes the hope for COVID‑19 containment at present. Since COVID‑19 pandemic is still the worldwide problem, the newly available vaccine is urgently registered and used in many countries. The main consideration is on the efficacy and safety of the new vaccine. Although there are some reports on COVID‑19 vaccine clinical trials, the data are from studies among healthy adult subjects.</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2776</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2776/717718617</pdf_url></Article></Articles>
